Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

CDK9 and Cancer

What is Cancer of Unknown Primary?

Exploiting Enzymes in Cancer Diagnosis and Therapy

British Pioneers in Cancer Biology

Cancer Pain

Cancer Screening Considerations: Balancing the Benefits and Risks

Cutaneous Manifestations of Internal Malignancy

Extracellular Vesicles as Floating Cancer Biomarkers

What Role do Biobanks Play in Cancer Research?

Living with Cancer Pain

What is Merkel Cell Carcinoma?

See more featured articles »

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Cancer Classification

The Cancer Cell Surface Proteome as a Therapeutic Target

Caring for a Loved One with Cancer

Microfluidic cancer treatment screen combined with flow cytometry

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Cancer Epidemiology

Targeted Cancer Therapies

Assay for Monitoring and Treating Malignant Brain Tumors

Hot vs Cold: the differences between tumor types

Cancer Prevention: Lowering your Risk

Investigating the Molecular Mechanisms of Cancer

Cancer Management

Hypoxia Markers and Their Importance

Myc Mutations and Cancer

Cancer Research

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

The Biochemistry of Breast Cancer Screening

Cancer Pathophysiology

Transforming Cancer Care through Genomic Testing

What is the Tumor Microenvironment?

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Pediatric Cancer

Why are Cancer Cell Lines Useful?

Effects of Social and Economic Deprivation on Cancer Mortality

Is Cancer a Metabolic Disorder?

Cancer Symptoms

Overview of Cell Viability and Cytotoxicity

Cancer Prognosis

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Insights into Oncofertility

Insight into Cancer Vaccines

What is Cancer?

Cancer History

What Causes Cancer?

What is Tumorigenesis?

The Effects of Cancer on Family Life

What is Immunochemotherapy?

TARDIS: The Improved Method of Detecting Breast Cancer

Secondary Brain Cancer

Cancer Glossary

Metastatic Migration in Cancer may be Influenced by Metabolism

Cancer Pain Management

Cancer Diagnosis

Using Biomarkers to Detect Cancer

Acidosis and Tumor Progression

Secondary Lung Cancer

Latest Cancer News and Research

Laser irradiation boosts antibody-antigen interactions to detect colorectal cancer

Researchers often use antibodies to detect specific molecules or biological markers, as they are remarkably precise at recognizing their targets.

25 Sep 2026

New project aims to make cellular therapies more accessible through room temperature storage

The Advanced Research Projects Agency for Health, or ARPA-H, has executed an award of up to $36.5 million in support of a University of California, Davis-led project aiming to make cellular therapies cheaper and more accessible through room temperature storage.

25 Sep 2026

Researchers find how prostate tumors reshape the immune microenvironment

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown pathway that prostate tumors leverage to suppress the immune system by reshaping the tumor microenvironment to resist treatment.

25 Sep 2026

In vivo CAR-T therapy transforms customized treatments into universal medicines

A collaborative team led by Professor Huji Xu from Naval Medical University, China, together with Professors Xuanming Yang and Yujia Cai at Shanghai Jiao Tong University, China, published a comprehensive review in Volume 2, article number 33 of the journal Immunity & Inflammation on August 31, 2026.

25 Sep 2026

Researchers find secret protein that drives cancer cell division

A previously unknown protein, hidden in RNA thought not to encode proteins, helps cells divide correctly. The RNA molecule that encodes the protein also has a function of its own in cell division.

25 Sep 2026

Study explains how stroke promotes aggressive glioma tumor growth

Researchers at Texas Children's Duncan Neurological Research Institute (Duncan NRI), Baylor College of Medicine and collaborating institutions show in Nature Cancer that stroke promotes glioma growth and uncovered cellular and molecular mediators involved in the process, linking brain injury to malignant brain tumors.

25 Sep 2026

Leica Biosystems brings Tempus pathology products to Aperio AI Store, accelerating AI-powered capabilities for oncology research

The Aperio AI Store integrates Tempus' AI applications, transforming complex pathology images into research insights and accelerating cancer diagnostics.

From Leica Biosystems 25 Sep 2026

Blood proteins may help monitor Alzheimer’s treatment response

Patients with early symptoms of Alzheimer's disease may be prescribed anti-amyloid therapy, which can help clear the sticky clumps of amyloid protein in the brain that characterize Alzheimer's.

25 Sep 2026

Neuromedin U drives immune suppression in aggressive prostate cancer

A new study from The Wistar Institute has found a link between the nervous system and the rapid development of neuroendocrine prostate cancer (NEPC), an aggressive form of the disease.

24 Sep 2026

Why are more younger adults in the Eastern Mediterranean facing colorectal cancer?

A 22-country analysis of modeled GLOBOCAN 2022 data found 15,381 early-onset colorectal cancer cases and 6,965 related deaths across the WHO Eastern Mediterranean Region, with substantial differences between countries and comparatively high mortality. Projections suggest that annual case and death counts could rise markedly by 2050, largely due to demographic change, while the findings support screening and detection strategies tailored to local resources and disease burden.

24 Sep 2026

USP15 enzyme emerges as potential target for ovarian cancer treatment

Ovarian cancer is often diagnosed after it has already spread to other parts of the body, at which point the five-year survival rate is under 30 percent.

24 Sep 2026

Uterus transplantation shows improving outcomes and successful births nationwide

A decade of uterus transplantation in the United States has resulted in dozens of healthy births and steadily improving surgical outcomes, according to a new national review led by researchers from the Perelman School of Medicine at the University of Pennsylvania.

24 Sep 2026

AI model predicts immunotherapy-related pneumonitis risk from CT scans

Researchers at The University of Texas MD Anderson Cancer Center have developed an artificial intelligence (AI) model that can identify lung cancer patients at increased risk of developing a serious immunotherapy-related side effect before treatment begins, offering a possible path toward more personalized monitoring and prevention strategies.

24 Sep 2026

Study identifies shared pathway driving cardiac fibrosis

Three adenosine receptor subtypes that normally send different signals were found to converge on a common pathway that activates cardiac fibroblasts, the scar-forming cells in the heart.

24 Sep 2026

MIT biologists discover cellular pathway that triggers colon cancer spread

Most colon cancer deaths are caused by the spread of tumor cells beyond the colon, usually to the liver. In a new study, MIT biologists identified a cellular pathway necessary for colorectal cancer metastasis.

24 Sep 2026

Multi-million dollar grants aim to advance hairy cell leukemia research

The Hairy Cell Leukemia Foundation and Blood Cancer United®, formerly The Leukemia & Lymphoma Society, today announced six new research grants as part of their ongoing strategic partnership to better understand what drives hairy cell leukemia and find better therapies on the road to cures for this rare form of blood cancer.

24 Sep 2026